Prostate Cancer Complexity

The Mormons' religious beliefs have proven to be quite a boon for cancer epidemiologists. Members of the Church of Jesus Christ of Latter-day Saints, following religious tenets, have meticulously recorded their family trees for centuries. Recognizing the research value of such data, Mark Skolnick, chief scientific officer at Myriad Genetics Inc. in Salt Lake City, computerized those records at the church's family history library 25 years ago. Recently, researchers had high hopes that the data wo

Written byEugene Russo
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Those hopes have been whittled down. So far, comprehensive family histories haven't elucidated the cancer's hereditary underpinnings--the genetic component of prostate cancer continues to confound loci researchers. And, these researchers are not the only ones scratching their heads. Those studying genes involved in prostate cancer tumorigenesis have been able to find only a few tumor suppressor genes specific to prostate cancer, which was diagnosed in 170,000 men last year. "There are a lot of ideas about how to pursue prostate cancer," says William Foulkes, an assistant professor of medicine at McGill University. "But it's not obvious that there's any new technique out there that's going to solve the problems suddenly."

Unlike colon or breast cancer research, research into prostate cancer, which killed 31,000 men in 2000, hasn't yet uncovered genes that provide real prognostic value. Studies investigating tumorigenesis, for example, speak to the biology of the cancer itself; they are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies